Ulf Björklund
Presidente presso REDWOOD PHARMA AB
Provenienza dei contatti di primo grado di Ulf Björklund
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Private Company | Household/Personal Care | 13 | |
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Other | 11 | |
| Public Company | Pharmaceuticals: Major | 11 | |
10
| Public Company | Biotechnology | 10 |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
OxyPharma AB
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ulf Björklund tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| CREATIVE ANTIBIOTICS SWEDEN AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| MEDCAP AB | Medical Specialties | Chairman Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Stockholm | College/University | Masters Business Admin Masters Business Admin | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Masters Business Admin | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree | |
| Umea Universitet | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Gothenburg | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| PHARMACOLOG I UPPSALA AB | Electronic Equipment/Instruments | Chairman Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Investor Relations Contact | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Aprea Personal AB | Chairman Chairman | ||
Natumin Pharma AB
 Natumin Pharma AB Pharmaceuticals: OtherHealth Technology Natumin Pharma AB operates as a research and development company in health care area. Its products include food supplements, cosmetics, dermatology, cosmeceuticals and medical devices. The company was founded by Lars Kärnerud in 1995 and is headquartered in Habo, Sweden. | Pharmaceuticals: Other | Chief Executive Officer General Counsel | |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Chairman Chairman | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
| AMNIOTICS AB | Biotechnology | Chairman Director/Board Member | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer Director/Board Member | |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Buhl Krone Holding ApS | Corporate Officer/Principal Chief Executive Officer |
Statistiche
Distribuzione geografica
| Svezia | 34 |
| Danimarca | 9 |
| Stati Uniti | 6 |
| Finlandia | 2 |
| Norvegia | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 340 |
| Corporate Officer/Principal | 116 |
| Chairman | 99 |
| Chief Executive Officer | 62 |
| Independent Dir/Board Member | 62 |
Contatti più connessi
- Borsa valori
- Insiders
- Ulf Björklund
- Connessioni Società
